CUMBERLAND PHARMACEUTICALS INC·4

Apr 29, 1:09 PM ET

Pavliv Leo 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Apr 29, 2022

Insider Transaction Report

Form 4
Period: 2022-03-16
Pavliv Leo
Vice President, Operations
Transactions
  • Award

    Options (right to buy)

    2022-03-16+5,0005,000 total
    Exercise: $2.59From: 2026-03-16Exp: 2032-03-16Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]100% vesting on March 16, 2026.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION